MEDIDAT
ActiveMEDIDAT has been active since 1985 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €66k and a net result of €-26k. Equity remains stable across the filed fiscal years (±0.5% per year). Its solvency ranks better than 81% of 15870 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability0▼-10
Solvency100=
Growth32▼-20
Stability100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity ample (current ratio 2.92 against 2.85 in 2023), and 21.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
78.1%
Return on assets
-30.7%
Age of the figures
20 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-09-2025, 55 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
55 d late
2023
30 d late
2022
32 d late
2021
20 d early
2020
67 d early
2019
36 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€66k▼ 28.2%
2023 · €92k
2018: €82k
2019: €90k
2020: €88k
2021: €90k
2022: €90k
2023: €92k
2018 → 2024
Total assets
€85k▼ 27.4%
2023 · €117k
2018: €153k
2019: €157k
2020: €154k
2021: €147k
2022: €129k
2023: €117k
2018 → 2024
Net result
€-26k
2023 · €2k
2018: €14k
2019: €8k
2020: €-2k
2021: €11k
2022: €299
2023: €2k
2018 → 2024
Working capital
€35k▼ 21.9%
2023 · €45k
2018: €23k
2019: €32k
2020: €16k
2021: €22k
2022: €32k
2023: €45k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€88k-€90k▲ 1.8%€90k▲ 0.3%€92k▲ 2.1%€66k▼ 28.2%
Operating result€-2k-€15k€1k▼ 91.2%€2k▲ 76.9%€-28k
Net result€-2k-€11k€299▼ 97.2%€2k▲ 527%€-26k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2024: a loss of €28k after €2k in 2023, the lowest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €85k
Fixed assets
€31k▼ 34.4%
Current assets
€54k▼ 22.8%
Equity and liabilities €85k
Equity
€66k▼ 28.2%
Debt
€19k▼ 24.4%
The debt ratio rises from 21.0% to 21.9%: equity shrinks faster than debt is paid down.
Key figures and ratios
EBITDA
€-9k▼
2023 · €21k
Cash flow
€-7k▼
2023 · €21k
Solvency
78.1%▼
2023 · 79.0%
Current ratio
2.92▲
2023 · 2.85
Quick ratio
2.59▲
2023 · 2.49
Debt / equity
0.28▲
2023 · 0.27
ROE
-39.3%▼
2023 · 2.0%
ROA
-30.7%▼
2023 · 1.6%
Interest coverage
-9.78▼
2023 · 23.21
Debt
€19k▼
2023 · €25k
Debt ≤ 1 year
€19k▼
2023 · €25k
Income taxes
€181▼
2023 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€117k€85k▼
Fixed assets21/28€47k€31k▼
Tangible fixed assets22/27€47k€28k▼
Land and buildings22€21k€16k▼
Furniture and vehicles24€25k€12k▼
Financial fixed assets28-€3k
Current assets29/58€70k€54k▼
Stocks and contracts in progress3€9k€6k▼
Stocks30/36€9k€6k▼
Amounts receivable within one year40/41€60k€47k▼
Trade receivables40€7k€3k▼
Other amounts receivable41€53k€44k▼
Deferred charges and accrued income490/1€1k€758▼
Equity and liabilities
Total equity and liabilities10/49€117k€85k▼
Equity10/15€92k€66k▼
Contributions10/11€53k€53k=
Reserves13€39k€39k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€37k€37k=
Profit (loss) carried forward14-€-26k
Amounts payable17/49€25k€19k▼
Amounts payable within one year42/48€25k€19k▼
Current portion of amounts payable after more than one year42€5k€64▼
Financial debts43€6k€2k▼
Credit institutions430/8€6k€2k▼
Trade debts44€11k€15k▲
Suppliers440/4€11k€15k▲
Taxes, remuneration and social security45€2k€2k▼
Taxes450/3€2k€2k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19k€19k▼
Other operating charges640/8€5k€4k▼
Gross operating margin9900€27k€-5k▼
Operating profit (loss)9901€2k€-28k▼
Financial income75/76B€3k€3k▲
Recurring financial income75€3k€3k▲
Financial charges65/66B€924€913▼
Recurring financial charges65€924€913▼
Profit (loss) for the period before taxes9903€4k€-26k▼
Income taxes67/77€2k€181▼
Profit (loss) for the period9904€2k€-26k▼
Profit (loss) for the period to be appropriated9905€2k€-26k▼
Appropriation of the result
Profit (loss) to be appropriated9906€2k€-26k▼
Transfer to equity691/2€2k-
To other reserves6921€2k-
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
24-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 55 days late
2024
31-12
Financial
Weakest financial yearnet €-26k ▼1484%
Net result drops to €-26k, the lowest in the series.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
11-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Back to profitnet €11k
Net result €11k after one loss-making year.
25-05
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
25-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
25-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
16-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
29-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 1985
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
De Bruynlaan 722610 AntwerpenGround area
737 m²
Building footprint
454 m²
Volume, LiDAR
5,104 m³
Parcel 11462A0005/00A005, Flanders · tallest building 14.4 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
LABO MEDIDAT
since 19852.028.295.140
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11462A0005/00A005 | Flanders | 737 m² | 1 · 454 m² | 14.4 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
The Hotel Company
BE 0747.583.849
Gent · Eq €66k
VET SHOPS
BE 0834.805.754
Lummen · Eq €65k
Scientific Activities and Researches in Quality of Life
BE 0667.670.893
Liège · Eq €65k
ARCHIMEDES
BE 0457.013.322
Mol · Eq €65k
Medilaser
BE 0507.928.721
Geel · Eq €65k
Of 1,895 companies in sector 46460 we hold annual accounts for 1,114. 531 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded18-11-1985
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 39 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.